MC 2083 2-Toluic acid, [carboxy-14C]- |
|
(ortho-Toluic acid, [carboxy-14C]-) | |
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
Ethanol solution, 100 μCi/ml | |
> 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 136.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 2216 3-Toluic acid, [ring-14C(U)]- |
|
(meta-Toluic acid, [ring-14C(U)]-) | |
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
Ethanol solution, 100 μCi/ml | |
> 70 mCi(2.59-2.96 GBq)/mmol | 50 μCi (1.85 MBq) $3970 |
NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $4670 |
M.W. 136.2 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 2252 4-Toluic acid, [carboxy-14C]- |
|
(para-Toluic acid, [carboxy-14C]-) | |
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
Ethanol solution, 100 μCi/ml | |
> 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
NextGen V-Vial - shipped on dry ice | |
M.W. 136.2 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |